PHARMAC makes cancer treatment available to more people

18 August 2022 - PHARMAC has confirmed today they are widening access from 1 September 2022 to a targeted cancer treatment, ...

Read more →

Stability of changes in health status: next step in comprehensively assessing patient reported outcomes

18 August 2022 - Chronic diseases can impair patients’ health status due to symptoms, functional limitations, and impaired quality of life. ...

Read more →

Canadians seek diabetes medication as replacement for weight loss drug during arrival delays

18 August 2022 - High demand in the United States for a new weight-loss medication has indefinitely delayed its arrival ...

Read more →

AARP Pennsylvania convenes discussion on lower prescription drug costs after Inflation Reduction Act signed into law

18 August 2022 - Senator Bob Casey joins AARP Discussion. ...

Read more →

Caps on prescription drug price hikes most popular aspect of Inflation Reduction Act: poll

18 August 2022 - A cap on prescription drug price increases is the most popular part of the Inflation Reduction ...

Read more →

CSL Vifor plans UK launch after NICE backs rare disease drug Tavneos

18 August 2022 - UK cost-effectiveness organisation NICE has recommended routine NHS use of a recently approved therapy for two ...

Read more →

Chiesi’s Trimbow recommended for use within NHS Scotland

18 August 2022 - The SMC approval brings much needed boost to asthma sufferers across Scotland. ...

Read more →

EMA starts review of conditional marketing authorisation application for Skycovion COVID-19 vaccine

18 August 2022 - The EMA’s CHMP has started a review of a conditional marketing authorisation application for Skycovion, a ...

Read more →

Restart of National Medicines Policy Review is welcome, but assurances needed over further consultation and feedback processes

18 August 2022 - Medicines Australia welcomes the restart of the National Medicines Policy Review, which was put on hold ...

Read more →

Valneva initiates rolling submission of FDA biologics license application for its single shot Chikungunya vaccine candidate

18 August 2022 - Valneva today announces that it has initiated rolling submission of the biologics license application to the ...

Read more →

FDA label update reflects Bayer’s commitment to providing options for long-acting contraception

18 August 2022 - FDA approves extension of Mirena (levonorgestrel-releasing intrauterine system) 52 mg intrauterine device for up to eight years ...

Read more →

Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma

18 August 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

U.S. FDA accepts Astellas' new drug application for fezolinetant

18 August 2022 - If approved by the FDA, fezolinetant would be a non-hormonal treatment for moderate to severe vasomotor ...

Read more →

Early phase oncology trials: why so many designs?

12 August 2022 - The past 30 years have seen a considerable effort on the part of statisticians to improve the ...

Read more →

IQWiG annual report for 2021 is available

17 August 2022 - The IQWiG has published its 2021 annual report today.  ...

Read more →